Pierre Socha

Pierre joined Amadeus Capital Partners in 2012 and leads early stage Health & Bio investments. He is on the boards of Inotec, Ori Biotech, PhoreMost, Quibim, Doctify, V7 and oversees our investments in Congenica, Lumeon and Organox.

Pierre has over a decade of entrepreneurial experience, having built and managed the growth of several life science businesses in Asia and Europe, from population genomics to medical nutrition.

Pierre speaks French and English.